MedPath

吉林长白山药业集团股份有限公司

Ownership
-
Established
1996-10-18
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

74

NMPA:74

Drug Approvals

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20249224
Approval Date
Oct 29, 2024
NMPA

Sitagliptin Phosphate and Metformin Hydrochloride Tablets (II)

Product Name
西格列汀二甲双胍片(Ⅱ)
Approval Number
国药准字H20244780
Approval Date
Sep 3, 2024
NMPA

颈腰康胶囊

Approval Number
国药准字Z20184005
Approval Date
Jan 9, 2023
NMPA

肾宝糖浆

Approval Number
国药准字Z22026290
Approval Date
Jul 12, 2021
NMPA

消癌平糖浆

Approval Number
国药准字Z20063535
Approval Date
Mar 10, 2021
NMPA

Pentoxyverine Citrate and Ammonium Chloride Syrup

Product Name
喷托维林氯化铵糖浆
Approval Number
国药准字H23022655
Approval Date
Aug 18, 2020
NMPA

升白康复口服液

Approval Number
国药准字B20020050
Approval Date
Jul 23, 2020
NMPA

银翘解毒液

Approval Number
国药准字Z22026292
Approval Date
Jul 23, 2020
NMPA

人参口服液

Approval Number
国药准字Z20027894
Approval Date
Jul 23, 2020
NMPA

鹿茸口服液

Approval Number
国药准字Z20027487
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.